日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium

一项IIa期多中心、随机、赋形剂对照、剂量递增研究，旨在评估CBT-001滴眼液治疗原发性或复发性翼状胬肉患者的安全性、有效性和药代动力学。

期刊:Ophthalmology Science
影响因子:4.6
doi:10.1016/j.xops.2024.100502
Whitcup, Scott M; Sall, Kenneth N; Hovanesian, John A; Goldberg, Damien F; Lee, Olivia L; Yang, Rong; Ni, Jinsong
发表日期：2024
文献求助 收藏

ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study Data

早期血管内皮生长因子抗治疗的解剖学反应与糖尿病性黄斑水肿长期预后之间的关联：一项基于Protocol i研究数据的独立分析

期刊:Retina-The Journal of Retinal and Vitreous Diseases
影响因子:2.1
doi:10.1097/IAE.0000000000002110
Dugel, Pravin U; Campbell, Joanna H; Kiss, Szilárd; Loewenstein, Anat; Shih, Vanessa; Xu, Xiaoshu; Holekamp, Nancy M; Augustin, Albert J; Ho, Allen C; Gonzalez, Victor H; Whitcup, Scott M
心血管
代谢
糖尿病
发表日期：2019
文献求助 收藏

Pharmacology of Corticosteroids for Diabetic Macular Edema

糖皮质激素治疗糖尿病性黄斑水肿的药理学

期刊:Investigative Ophthalmology & Visual Science
影响因子:4.7
doi:10.1167/iovs.17-22259
Whitcup, Scott M; Cidlowski, John A; Csaky, Karl G; Ambati, Jayakrishna
代谢
糖尿病
免疫/内分泌
发表日期：2018
文献求助 收藏

Bimatoprost 0.03% for the Treatment of Eyebrow Hypotrichosis

比马前列素 0.03% 用于治疗眉毛稀疏症

期刊:Dermatologic Surgery
影响因子:2.2
doi:10.1097/DSS.0000000000000755
Carruthers, Jean; Beer, Kenneth; Carruthers, Alastair; Coleman, William P 3rd; Draelos, Zoe Diana; Jones, Derek; Goldman, Mitchel P; Pucci, Michael L; VanDenburgh, Amanda; Weng, Emily; Whitcup, Scott M
发表日期：2016
文献求助 收藏

Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study

地塞米松玻璃体内植入剂用于既往接受过治疗的糖尿病性黄斑水肿患者：MEAD 研究的亚组分析

期刊:BMC Ophthalmology
影响因子:1.7
doi:10.1186/s12886-015-0148-2
Augustin, Albert J; Kuppermann, Baruch D; Lanzetta, Paolo; Loewenstein, Anat; Li, Xiao-Yan; Cui, Harry; Hashad, Yehia; Whitcup, Scott M
糖尿病
代谢
发表日期：2015
文献求助 收藏

Inflammation in retinal disease

视网膜疾病中的炎症

期刊:International Journal of Inflammation
影响因子:2
doi:10.1155/2013/724648
Whitcup, Scott M; Nussenblatt, Robert B; Lightman, Susan L; Hollander, David A
炎症/感染
Immunology/Inflammation
炎症
发表日期：2013
文献求助 收藏

Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trials

比马前列素滴眼液0.03%的长期安全性评价：六项双盲、随机、活性对照临床试验的汇总分析

期刊:Clinical Ophthalmology
影响因子:2.2
doi:10.2147/OPTH.S17457
Wirta, David; Vandenburgh, Amanda M; Weng, Emily; Whitcup, Scott M; Kurstjens, Sef; Beddingfield, Frederick C 3rd
发表日期：2011
文献求助 收藏

Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications

用于治疗视网膜疾病的眼科药物输送系统：从基础研究到临床应用

期刊:Investigative Ophthalmology & Visual Science
影响因子:4.7
doi:10.1167/iovs.10-5392
Edelhauser, Henry F; Rowe-Rendleman, Cheryl L; Robinson, Michael R; Dawson, Daniel G; Chader, Gerald J; Grossniklaus, Hans E; Rittenhouse, Kay D; Wilson, Clive G; Weber, David A; Kuppermann, Baruch D; Csaky, Karl G; Olsen, Timothy W; Kompella, Uday B; Holers, V Michael; Hageman, Gregory S; Gilger, Brian C; Campochiaro, Peter A; Whitcup, Scott M; Wong, Wai T
发表日期：2010
文献求助 收藏

A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprost

一项随机对照试验，比较了先前接受拉坦前列素治疗的患者，分别接受 0.01% 比马前列素或赋形剂治疗后，肉眼可见的结膜充血情况。

期刊:Clinical Ophthalmology
影响因子:2.2
doi:10.2147/OPTH.S14915
Craven, E Randy; Liu, Ching-Chi; Batoosingh, Amy; Schiffman, Rhett M; Whitcup, Scott M
发表日期：2010
文献求助 收藏

Birdshot retinochoroidopathy

鸟枪状视网膜脉络膜病变

期刊:British Journal of Ophthalmology
影响因子:3.5
doi:10.1136/bjo.83.2.241
Gasch, A T; Smith, J A; Whitcup, S M
Bird
发表日期：1999
文献求助 收藏